ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 128 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $413,740 | -33.9% | 60,400 | 0.0% | 0.00% | – |
| Q2 2023 | $626,348 | +28.2% | 60,400 | 0.0% | 0.00% | – |
| Q1 2023 | $488,636 | -48.6% | 60,400 | 0.0% | 0.00% | – |
| Q4 2022 | $951,300 | +31.0% | 60,400 | +31.0% | 0.00% | – |
| Q3 2022 | $726,000 | +12.7% | 46,100 | 0.0% | 0.00% | – |
| Q2 2022 | $644,000 | -10.7% | 46,100 | +10.3% | 0.00% | – |
| Q1 2022 | $721,000 | +52.1% | 41,800 | +28.2% | 0.00% | – |
| Q4 2021 | $474,000 | -5.2% | 32,600 | +17.3% | 0.00% | – |
| Q3 2021 | $500,000 | +2.5% | 27,800 | 0.0% | 0.00% | – |
| Q2 2021 | $488,000 | +756.1% | 27,800 | -49.6% | 0.00% | – |
| Q1 2020 | $57,000 | -45.2% | 55,200 | 0.0% | 0.00% | – |
| Q4 2019 | $104,000 | +73.3% | 55,200 | 0.0% | 0.00% | – |
| Q3 2019 | $60,000 | -50.4% | 55,200 | 0.0% | 0.00% | – |
| Q2 2019 | $121,000 | -57.5% | 55,200 | +16.2% | 0.00% | – |
| Q1 2019 | $285,000 | -2.4% | 47,500 | +20.3% | 0.00% | – |
| Q4 2018 | $292,000 | -35.0% | 39,500 | +27.8% | 0.00% | – |
| Q3 2018 | $449,000 | -21.9% | 30,900 | +7.3% | 0.00% | – |
| Q2 2018 | $575,000 | +39.2% | 28,800 | +22.0% | 0.00% | – |
| Q1 2018 | $413,000 | -14.1% | 23,600 | +21.0% | 0.00% | – |
| Q4 2017 | $481,000 | -4.4% | 19,500 | 0.0% | 0.00% | – |
| Q3 2017 | $503,000 | -4.9% | 19,500 | 0.0% | 0.00% | – |
| Q2 2017 | $529,000 | +91.0% | 19,500 | +109.7% | 0.00% | – |
| Q1 2017 | $277,000 | +35.8% | 9,300 | +24.0% | 0.00% | – |
| Q4 2016 | $204,000 | – | 7,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,954,904 | $49,264,000 | 43.26% |
| COMMODORE CAPITAL LP | 1,028,084 | $25,908,000 | 10.32% |
| Foresite Capital Management IV, LLC | 3,399,034 | $85,656,000 | 10.26% |
| VR Adviser, LLC | 3,720,582 | $93,759,000 | 10.17% |
| Parkman Healthcare Partners LLC | 1,709,136 | $43,070,000 | 10.00% |
| Foresite Capital Management V, LLC | 1,258,243 | $31,708,000 | 9.32% |
| Stenahm Asset Managment Ltd | 283,500 | $7,144,000 | 5.04% |
| Samsara BioCapital, LLC | 1,022,612 | $25,770,000 | 4.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 336,737 | $8,486,000 | 4.63% |
| Ghost Tree Capital, LLC | 600,000 | $15,120,000 | 3.55% |